All Insights Conversations Progress Press Characterizing/Advancing Higher-exposure Dosing Date published: January 3, 2026 6:35 pm PST Share Copied! Project Ascend is Skye’s 90-day roadmap to validate higher-exposure dosing for nimacimab and strengthen the clinical and translational evidence behind peripheral CB1 inhibition in obesity.